BR0117106A - Compostos de lipossoma de microesfera de gás - Google Patents
Compostos de lipossoma de microesfera de gásInfo
- Publication number
- BR0117106A BR0117106A BR0117106-2A BR0117106A BR0117106A BR 0117106 A BR0117106 A BR 0117106A BR 0117106 A BR0117106 A BR 0117106A BR 0117106 A BR0117106 A BR 0117106A
- Authority
- BR
- Brazil
- Prior art keywords
- gas
- microsphere
- filled
- microsphere liposome
- lipid
- Prior art date
Links
- 239000004005 microsphere Substances 0.000 title abstract 6
- 239000002502 liposome Substances 0.000 title abstract 5
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001435 Thromboembolism Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 125000003473 lipid group Chemical group 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012285 ultrasound imaging Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Acoustics & Sound (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Radiology & Medical Imaging (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"COMPOSTOS DE LIPOSSOMA DE MICROESFERA DE GáS". São descritas formulações compreendendo um composto de lipossoma de microesfera de gás suspenso em um meio, onde o composto de lipossoma de microesfera de gás compreende: uma microesfera cheia de gás; pelo menos um de lipídeo e tensoativo adsorvido na superfície da microesfera cheia de gás; e lipossomas cheios de líquido anexados ao lipídeo ou tensoativo. São também descritos processos para preparação das formulações e uso das mesmas na formação de imagem de ultra-som. A presente invenção também compreende o uso das mesmas no tratamento de doenças do coração, inflamação, infecção, câncer ou doença tromboembólica em um paciente.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/025685 WO2003015831A1 (en) | 2001-08-16 | 2001-08-16 | Gas microsphere liposome composites |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0117106A true BR0117106A (pt) | 2004-08-17 |
Family
ID=21742778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0117106-2A BR0117106A (pt) | 2001-08-16 | 2001-08-16 | Compostos de lipossoma de microesfera de gás |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1416974A1 (pt) |
JP (1) | JP2005505532A (pt) |
KR (1) | KR20040030121A (pt) |
CN (1) | CN1620314A (pt) |
BR (1) | BR0117106A (pt) |
CA (1) | CA2456988A1 (pt) |
IL (1) | IL160228A0 (pt) |
MX (1) | MXPA04001468A (pt) |
NO (1) | NO20040654L (pt) |
PL (1) | PL368072A1 (pt) |
WO (1) | WO2003015831A1 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9364569B2 (en) | 2003-02-04 | 2016-06-14 | Bracco Suisse S.A. | Ultrasound contrast agents and process for the preparation thereof |
AU2004255160A1 (en) * | 2003-06-13 | 2005-01-20 | Imarx Therapeutics, Inc. | Non-invasive intravascular thrombolyisis using modified ultrasound techniques |
JP2005154282A (ja) * | 2003-11-20 | 2005-06-16 | Mebiopharm Co Ltd | ガス封入リポソームの製造法 |
CA2547024C (en) | 2003-12-22 | 2013-12-17 | Bracco Research Sa | Gas-filled microvesicle assembly for contrast imaging |
WO2005063306A1 (en) * | 2003-12-22 | 2005-07-14 | Bracco Research Sa | Assembly of gas-filled microvesicle with active component for contrast imaging |
CN101389273B (zh) * | 2004-08-05 | 2012-09-05 | 贝勒研究院 | 基因或药物递送系统 |
WO2006018433A1 (en) | 2004-08-18 | 2006-02-23 | Bracco Research Sa | Gas-filled microvesicles composition for contrast imaging |
US20080019918A1 (en) * | 2004-09-10 | 2008-01-24 | Takao Aoki | Medicinal Preparation |
WO2006089245A2 (en) * | 2005-02-16 | 2006-08-24 | Univ California | Bubble architectures and methods of making and using thereof |
AU2005332157A1 (en) * | 2005-05-23 | 2006-11-30 | Mebiopharm Co., Ltd., | Method of producing liposomes containing gas enclosed therein |
US8257338B2 (en) | 2006-10-27 | 2012-09-04 | Artenga, Inc. | Medical microbubble generation |
CN101365424A (zh) * | 2005-12-08 | 2009-02-11 | 耶路撒冷希伯来大学伊森姆研究发展公司 | 通过超声辐射改变脂质体组成的方法 |
WO2008079834A2 (en) * | 2006-12-21 | 2008-07-03 | Lantheus Medical Imaging, Inc. | Preparation of paramagnetic nanoparticles conjugated to leukotriene b4 (ltb4) receptor antagonists, and their use as mri contrast agents for the detection of infection and inflammation |
DE102007008484A1 (de) * | 2007-02-19 | 2008-08-21 | Epo Experimentelle Pharmakologie & Onkologie Berlin-Buch Gmbh | Pharmazeutische Zubereitung zur Bekämpfung von Metastasen |
WO2009049089A1 (en) | 2007-10-09 | 2009-04-16 | Washington University In St. Louis | Ligand directed toroidal nanoparticles for therapy and diagnostic imaging |
CN101868180A (zh) | 2007-10-09 | 2010-10-20 | 圣路易斯华盛顿州立大学 | 成像粒子 |
KR101006347B1 (ko) * | 2008-08-05 | 2011-01-10 | 주식회사 이엠따블유 | 스피커 일체형 안테나 |
EP2512452B1 (en) * | 2009-12-17 | 2018-09-19 | The Washington University | Antithrombotic nanoparticle |
US9808500B2 (en) | 2009-12-17 | 2017-11-07 | Washington University | Antithrombotic nanoparticle |
AU2011239414A1 (en) | 2010-04-15 | 2012-11-08 | The Washington University | Prodrug compositions, prodrug nanoparticles, and methods of use thereof |
WO2012098937A1 (ja) * | 2011-01-21 | 2012-07-26 | 国立大学法人 神戸大学 | リポソームの製造方法 |
EP2748299B1 (en) * | 2011-08-24 | 2018-03-14 | The Regents of The University of California | Targeting microbubbles |
CN102764456B (zh) * | 2012-07-24 | 2014-10-15 | 上海交通大学 | 血管栓塞剂及其用途、制备方法 |
WO2015133828A1 (ko) * | 2014-03-07 | 2015-09-11 | 주식회사 퍼시픽시스템 | 약물 전달을 위해 기포를 포함하는 미셀 및 이를 제작하는 방법 |
US10804769B2 (en) | 2015-06-17 | 2020-10-13 | Covidien Lp | Surgical instrument with phase change cooling |
CN105169420B (zh) * | 2015-09-02 | 2018-01-05 | 上海市第十人民医院 | 一种新型射频诊疗剂及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620689A (en) * | 1989-10-20 | 1997-04-15 | Sequus Pharmaceuuticals, Inc. | Liposomes for treatment of B-cell and T-cell disorders |
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
AU7655194A (en) * | 1993-09-09 | 1995-03-27 | Schering Aktiengesellschaft | Active principles and gas containing microparticles |
US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
ES2244169T3 (es) * | 1998-02-09 | 2005-12-01 | Bracco International B.V. | Suministro direccionado de medios biologicamente activos. |
-
2001
- 2001-08-16 CN CNA018237088A patent/CN1620314A/zh active Pending
- 2001-08-16 PL PL01368072A patent/PL368072A1/xx not_active Application Discontinuation
- 2001-08-16 MX MXPA04001468A patent/MXPA04001468A/es not_active Application Discontinuation
- 2001-08-16 KR KR10-2004-7002278A patent/KR20040030121A/ko not_active Application Discontinuation
- 2001-08-16 EP EP01967995A patent/EP1416974A1/en not_active Withdrawn
- 2001-08-16 WO PCT/US2001/025685 patent/WO2003015831A1/en not_active Application Discontinuation
- 2001-08-16 BR BR0117106-2A patent/BR0117106A/pt not_active IP Right Cessation
- 2001-08-16 JP JP2003520788A patent/JP2005505532A/ja active Pending
- 2001-08-16 IL IL16022801A patent/IL160228A0/xx unknown
- 2001-08-16 CA CA002456988A patent/CA2456988A1/en not_active Abandoned
-
2004
- 2004-02-13 NO NO20040654A patent/NO20040654L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL160228A0 (en) | 2004-07-25 |
WO2003015831A1 (en) | 2003-02-27 |
EP1416974A1 (en) | 2004-05-12 |
NO20040654L (no) | 2004-05-14 |
PL368072A1 (en) | 2005-03-21 |
CN1620314A (zh) | 2005-05-25 |
KR20040030121A (ko) | 2004-04-08 |
JP2005505532A (ja) | 2005-02-24 |
MXPA04001468A (es) | 2004-05-20 |
CA2456988A1 (en) | 2003-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0117106A (pt) | Compostos de lipossoma de microesfera de gás | |
TR200002218T2 (tr) | 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri | |
DK0616508T3 (da) | Gasfyldte liposomer og anvendelse deraf som ultralydkontrastmidler | |
EA200001223A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
FI953442A (fi) | Gonadotropiinia sisältäviä pakastekuivattuja pallosia | |
EA200001224A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
WO2002072011A3 (en) | Stabilized therapeutic and imaging agents | |
IT8419308A0 (it) | Procedimento per la preparazione di formulazioni galeniche particolarmente per uso farmaceutico, dietetico, cosmetico e diagnostico. | |
ES2052732T3 (es) | 2',3'-didesoxi-3'-fluorotimidina y compuestos afines para el tratamiento de infecciones por adenovirus. | |
ES2157886T3 (es) | Composiciones tensioactivas y procedimientos. | |
NO962006D0 (no) | Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem | |
NO965483L (no) | Dinukleosid-5',5'-pyrofosfater | |
IT9019914A0 (it) | Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria | |
EP1245562A4 (en) | ALCOHOLS 5-THIA- "OMEGA" - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT. | |
IT1164363B (it) | Procedimento terapeutico facente uso di liposomi imcorporati fruttosio 1,6 difosfato e procedimento per la preparazione degli stessi | |
DK0934342T3 (da) | Præparat indeholdende chitosan | |
ITTO930667A0 (it) | Procedimento per la preparazione di ethalfluralin | |
ITMI992457A0 (it) | Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide | |
ITMI20011237A0 (it) | Uso della yohimbina per la preparazione di farmaci ad attivita' immunobiologica | |
ITMI982246A0 (it) | Uso di androst-5-ene-3beta,7beta-17beta-triolo per la preparazione di un medicamento utile per il trattamento dello stress cronico | |
ITRM940453A0 (it) | "uso della proteina p1lsa per la preparazione di un medicamento da utilizzarsi nella terapia di patologie indotte da danni cellulari da agenti fisici, chimici o biologici" | |
ITMI940598A0 (it) | Telaio di supporto per la realizzazione di pareti trasparenti, semitrasparenti luci o simili | |
ITMI940414A0 (it) | Procedimento per la coniugazione di proteine di interesse terapeutico o diagnostico | |
ITMI940785A0 (it) | Procedimento per la preparazione di esteri 3-vinil-cefalosporanici | |
ITMI940613A0 (it) | Procedimento per la preparazione di 17-idrossi-1-alfa, 2-alfa -metilenepregna-4, 6-dien-3,20-dione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 6A, 7A E 8A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009. |